1. SafeRisk acquisition - India Insure is acquiring 100% of Saferisk Insurance Brokers, a Bhubaneswar-based broker with FY25 turnover of ₹27.78 crore and net worth of ₹17.91 crore, for a mix of cash (₹55.1 crore) and share swap (₹29.7 crore), subject to IRDAI approval. The acquired book adds roughly 11% to group revenue at one stroke, with integration via merger into India Insure already planned.
2. ₹65 crore NCD fundraise - India Insure allotted ₹65 crore of secured NCDs to Kotak Credit Opportunities Fund on 30 March 2026, carrying a 12% cash coupon and 15.5% blended IRR, with principal repayment starting from Q5. The funds strengthen the balance sheet for the acquisition pipeline and working capital at a time when the group is actively negotiating two further deals.
3. Retail health and life margin shift - Management is steering the retail book away from motor insurance (85% of the segment) toward higher-margin health and life products, with manpower added and a nationwide InsureEasy platform launch targeted by Q4 FY26. This directly lifts blended margins in a segment that already doubled revenue year-on-year in Q3 FY25.
4. Reinsurance alternate strategy - After regulatory headwinds caused a revenue drop in reinsurance, an alternate strategy is underway to refocus on M&A and other specialty products, aiming to recoup revenues within two quarters. Reinsurance carries superior margins and annuity-like revenue streams, so a recovery restores a high-quality earnings layer that contributed 17% of FY25 GWP.
5. International expansion in Sri Lanka and Maldives - Sri Lanka contributed ₹908 million (6%) and Maldives ₹120 million (1%) of FY26 GWP, with the Maldives non-life market growing at an estimated 18% CAGR over five years and Sri Lanka’s broker share expected to rise. These markets are early-stage replications of the India model, offering a growth runway outside a 93%-India GWP base.
6. NSE dual listing - The board approved an application on 18 June 2026 to list existing equity shares on the NSE main board without a fresh issue of capital. A move to NSE broadens the investor base and can improve trading liquidity for a ₹879-crore market-cap company currently listed only on BSE.
7. Pipeline of further acquisitions - Management reports advanced discussions for two additional acquisition opportunities that could deliver “quantum growth,” and is evaluating avenues to line up additional funds. With the SafeRisk template established and NCD funding in place, a second deal would compound the inorganic growth trajectory.